BRPI1013254A2 - sais de (r)-7-[3-amino-4-(2,4,5-trifluoro-fenil)-butiril]-3-trifluorometil-5,6,7,8-tetra-hidro-imidazo[1,5-a]pirazina-1-carboxilato de metila. - Google Patents
sais de (r)-7-[3-amino-4-(2,4,5-trifluoro-fenil)-butiril]-3-trifluorometil-5,6,7,8-tetra-hidro-imidazo[1,5-a]pirazina-1-carboxilato de metila.Info
- Publication number
- BRPI1013254A2 BRPI1013254A2 BRPI1013254A BRPI1013254A BRPI1013254A2 BR PI1013254 A2 BRPI1013254 A2 BR PI1013254A2 BR PI1013254 A BRPI1013254 A BR PI1013254A BR PI1013254 A BRPI1013254 A BR PI1013254A BR PI1013254 A2 BRPI1013254 A2 BR PI1013254A2
- Authority
- BR
- Brazil
- Prior art keywords
- butyryl
- imidazo
- pyrazine
- trifluoro
- tetrahydro
- Prior art date
Links
- -1 2,4,5-trifluoro-phenyl Chemical group 0.000 title 1
- NECMIXDTENBWRG-UHFFFAOYSA-N 2h-pyrazine-1-carboxylic acid Chemical compound OC(=O)N1CC=NC=C1 NECMIXDTENBWRG-UHFFFAOYSA-N 0.000 title 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101452378A CN101899048B (zh) | 2009-05-27 | 2009-05-27 | (R)-7-[3-氨基-4-(2,4,5-三氟-苯基)-丁酰]-3-三氟甲基-5,6,7,8-四氢-咪唑并[1,5-a]吡嗪-1-羧酸甲酯的盐 |
PCT/CN2010/072319 WO2010135944A1 (zh) | 2009-05-27 | 2010-04-29 | (R)-7-[3-氨基-4-(2,4,5-三氟-苯基)-丁酰]-3-三氟甲基-5,6,7,8-四氢-咪唑并[1,5-a]吡嗪-1-羧酸甲酯的盐 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1013254A2 true BRPI1013254A2 (pt) | 2016-04-05 |
Family
ID=43222148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1013254A BRPI1013254A2 (pt) | 2009-05-27 | 2010-04-29 | sais de (r)-7-[3-amino-4-(2,4,5-trifluoro-fenil)-butiril]-3-trifluorometil-5,6,7,8-tetra-hidro-imidazo[1,5-a]pirazina-1-carboxilato de metila. |
Country Status (15)
Country | Link |
---|---|
US (1) | US8618104B2 (pt) |
EP (1) | EP2436684B1 (pt) |
JP (1) | JP5756798B2 (pt) |
KR (1) | KR101769775B1 (pt) |
CN (1) | CN101899048B (pt) |
AU (1) | AU2010252508B2 (pt) |
BR (1) | BRPI1013254A2 (pt) |
CA (1) | CA2762917C (pt) |
ES (1) | ES2535806T3 (pt) |
HK (1) | HK1147758A1 (pt) |
MX (1) | MX2011012557A (pt) |
RU (1) | RU2528233C2 (pt) |
UA (1) | UA105928C2 (pt) |
WO (1) | WO2010135944A1 (pt) |
ZA (1) | ZA201108032B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI494313B (zh) * | 2010-12-29 | 2015-08-01 | Jiangsu Hengrui Medicine Co | 治療包括人類之哺乳動物中第2型糖尿病的醫藥組成物 |
CN106892926B (zh) * | 2012-10-16 | 2019-09-06 | 江苏盛迪医药有限公司 | 一种dpp-iv抑制剂的中间体、其制备方法和通过其制备dpp-iv抑制剂的方法 |
CN103664962A (zh) * | 2013-12-20 | 2014-03-26 | 南京华威医药科技开发有限公司 | 哌嗪类衍生物 |
CN103910734B (zh) * | 2014-03-28 | 2016-01-13 | 南京华威医药科技开发有限公司 | 一种具有哌嗪结构的dpp-4抑制剂 |
CN108236611A (zh) * | 2016-12-27 | 2018-07-03 | 江苏恒瑞医药股份有限公司 | 两种化合物联合在制备治疗糖尿病药物中的用途 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5462928A (en) | 1990-04-14 | 1995-10-31 | New England Medical Center Hospitals, Inc. | Inhibitors of dipeptidyl-aminopeptidase type IV |
IL111785A0 (en) | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
US5543396A (en) | 1994-04-28 | 1996-08-06 | Georgia Tech Research Corp. | Proline phosphonate derivatives |
GB0115517D0 (en) * | 2001-06-25 | 2001-08-15 | Ferring Bv | Novel antidiabetic agents |
UA74912C2 (en) * | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
CA2478389A1 (en) | 2002-03-25 | 2003-10-09 | Merck & Co., Inc. | Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
ES2291680T3 (es) | 2002-10-07 | 2008-03-01 | MERCK & CO., INC. | Antidiabeticos beta-amino heterociclicos inhibidores de la dipeptidil peptidasa. |
CA2508947A1 (en) * | 2002-12-20 | 2004-07-15 | Merck & Co., Inc. | 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
WO2004085661A2 (en) | 2003-03-24 | 2004-10-07 | Merck & Co., Inc | Process to chiral beta-amino acid derivatives |
JO2625B1 (en) | 2003-06-24 | 2011-11-01 | ميرك شارب اند دوم كوربوريشن | Phosphoric acid salts of dipeptidyl betidase inhibitor 4 |
CN101365432B (zh) * | 2005-12-16 | 2011-06-22 | 默沙东公司 | 二肽基肽酶-4抑制剂与二甲双胍的组合的药物组合物 |
ES2439255T3 (es) * | 2007-06-21 | 2014-01-22 | Cara Therapeutics, Inc. | Imidazoheterociclos sustituidos |
CN101417999A (zh) | 2007-10-25 | 2009-04-29 | 上海恒瑞医药有限公司 | 哌嗪类衍生物,其制备方法及其在医药上的应用 |
CN101468988A (zh) * | 2007-12-26 | 2009-07-01 | 上海恒瑞医药有限公司 | 哌嗪类衍生物,其制备方法及其在医药上的应用 |
CN101824036A (zh) * | 2009-03-05 | 2010-09-08 | 上海恒瑞医药有限公司 | 四氢咪唑并[1,5-a]吡嗪衍生物的盐,其制备方法及其在医药上的应用 |
KR101686265B1 (ko) * | 2010-03-08 | 2016-12-13 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 타입 2 당뇨병 치료용 약학적 조성물 |
-
2009
- 2009-05-27 CN CN2009101452378A patent/CN101899048B/zh active Active
-
2010
- 2010-04-29 JP JP2012512185A patent/JP5756798B2/ja not_active Expired - Fee Related
- 2010-04-29 AU AU2010252508A patent/AU2010252508B2/en not_active Ceased
- 2010-04-29 MX MX2011012557A patent/MX2011012557A/es not_active Application Discontinuation
- 2010-04-29 CA CA2762917A patent/CA2762917C/en not_active Expired - Fee Related
- 2010-04-29 WO PCT/CN2010/072319 patent/WO2010135944A1/zh active Application Filing
- 2010-04-29 KR KR1020117030941A patent/KR101769775B1/ko not_active Application Discontinuation
- 2010-04-29 RU RU2011149160/04A patent/RU2528233C2/ru not_active IP Right Cessation
- 2010-04-29 BR BRPI1013254A patent/BRPI1013254A2/pt not_active IP Right Cessation
- 2010-04-29 ES ES10780026.0T patent/ES2535806T3/es active Active
- 2010-04-29 UA UAA201113931A patent/UA105928C2/uk unknown
- 2010-04-29 US US13/322,142 patent/US8618104B2/en not_active Expired - Fee Related
- 2010-04-29 EP EP10780026.0A patent/EP2436684B1/en not_active Not-in-force
-
2011
- 2011-02-28 HK HK11101956.7A patent/HK1147758A1/xx unknown
- 2011-11-02 ZA ZA2011/08032A patent/ZA201108032B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2436684A4 (en) | 2012-12-19 |
ZA201108032B (en) | 2012-07-25 |
AU2010252508B2 (en) | 2015-08-20 |
KR101769775B1 (ko) | 2017-08-21 |
CA2762917A1 (en) | 2010-12-02 |
AU2010252508A2 (en) | 2012-06-07 |
EP2436684B1 (en) | 2015-03-04 |
EP2436684A1 (en) | 2012-04-04 |
UA105928C2 (uk) | 2014-07-10 |
US20120122875A1 (en) | 2012-05-17 |
ES2535806T3 (es) | 2015-05-18 |
JP2012528082A (ja) | 2012-11-12 |
RU2528233C2 (ru) | 2014-09-10 |
CN101899048A (zh) | 2010-12-01 |
KR20120028939A (ko) | 2012-03-23 |
MX2011012557A (es) | 2011-12-14 |
HK1147758A1 (pt) | 2011-08-19 |
CN101899048B (zh) | 2013-04-17 |
US8618104B2 (en) | 2013-12-31 |
JP5756798B2 (ja) | 2015-07-29 |
AU2010252508A1 (en) | 2012-01-19 |
WO2010135944A1 (zh) | 2010-12-02 |
RU2011149160A (ru) | 2013-07-10 |
CA2762917C (en) | 2017-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTPA2021504I1 (lt) | 5-Fenil-[1,2,4]triazolo[1,5-a]piridin-2-ilo karboksamidai, kaip JAK slopikliai | |
SMT201600155B (it) | Pirazolo[i, 5-a]pirimidine e -triazine come agenti antivirali | |
BR112013015959A2 (pt) | Derivados de 2-arilimidazo [1,2-b] piridazina, 2- fenilimidazo [1,2-a] piridina, e 2-fenilimidazo [1,2-a] pirazina. | |
SMT201400123B (it) | Imidazo[1,2B]piridazine sostituite come inibitori di trk-chinasi | |
BRPI0919292A2 (pt) | 3h-imidazo[4,5-b] piridina-6-carboxamidas como agentes anti-inflamatórios | |
EP2608669A4 (en) | NEW PYRAZOLO- [1,5-A-] PYRIMIDINE DERIVATIVES AS ANTI-MTOR HEMMER | |
DK2384326T3 (da) | Pyrrolo[2,3-d]pyrimidinforbindelser | |
PT2794611T (pt) | Pirazolo[1,5-a]pirimidinas como agentes antivirais | |
BRPI1008850A2 (pt) | [1,2,4]triazolo[1,5-a]piridinas como inibidores de quinase | |
DK3106463T6 (da) | Pyrazolo[1,5-]pyrimidinforbindelse som trk-kinasehæmmer | |
AP2011005807A0 (en) | 3H-imidazo[4,5-C] pyridine-6-carboxamides as anti-inflammatory agents. | |
BRPI0822237A2 (pt) | Compostos de imidazo [1,2-a] piridina | |
BRPI0919948A2 (pt) | Pirido[4,3-b]indois contendo porções rígidas | |
BR112013012965A2 (pt) | derivados de imidazo (1,2-b] piridazina e imidazo [4, 5 -b] piridina como inibidores de jak | |
BR112013022917A2 (pt) | derivados 3,4-dihidro-pirrolo[1,2-a]pirazino-1-ilamina úteis como inibidores de beta-secretase (bace) | |
EP2525659A4 (en) | PYRAZOLO [1,5-A] PYRIMIDINES COMPOUNDS AS MTOR INHIBITORS | |
BR112012002110A2 (pt) | derivados de pirrolo[1,2-b]piridazina como inibidores de janus cinase | |
SI2124944T1 (sl) | Derivati pirazolo b piridina kot inhibitorji fosfodiesteraze | |
BRPI0915417A2 (pt) | derivados de 3-(3-pirimidin-2-il-benzil)-[1,2,4]triazolo [4,3-b]piridazina como inibidores da met quinase | |
IL229993A (en) | 8 - Alkoxy [1,2,4] triazolo [5,1 – c] pyrimidine– 2 | |
EP2142542A4 (en) | NEW IMIDAZO [4,5-B] PYRIDINE-7-CARBOXYLAMIDEAMIDE 704 | |
BRPI0822239A2 (pt) | Composto de pirazolo[1,5-a] pirimidina | |
IL221479A0 (en) | Triazolo [4,5-b] pyridin derivatives | |
ZA201406323B (en) | Triazolo[4,5-d]pyrimidine derivatives | |
BRPI1013254A2 (pt) | sais de (r)-7-[3-amino-4-(2,4,5-trifluoro-fenil)-butiril]-3-trifluorometil-5,6,7,8-tetra-hidro-imidazo[1,5-a]pirazina-1-carboxilato de metila. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2512 DE 26-02-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |